Back
United States Lime & Minerals Vs. Kymera Therapeutics Industry Stock Comparison
Buy
83
USLM
United States Lime & Minerals
Last Price:
103.74
Seasonality Move:
6.24%
Buy
71
KYMR
Kymera Therapeutics
Last Price:
46.30
Seasonality Move:
65.72%
Buy
83
United States Lime & Minerals (USLM)
is a Buy
Is United States Lime & Minerals a Buy, Sell or Hold?
- The current United States Lime & Minerals [USLM] share price is $103.60. The Score for USLM is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- USLM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
USLM Stock Price Chart
What is United States Lime & Minerals's stock price today?
-
The United States Lime & Minerals share price today is $103.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USLM is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
USLM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.45 | Buy |
Relative Strength Index (14 RSI): | 75.46 | Buy |
Chaikin Money Flow: | 36503 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 59.12 | Buy |
Chaikin Money Flow: | 317205 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
USLM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 99.17 | Buy |
20-day SMA: | 96.31 | Buy |
50-day SMA: | 85.53 | Buy |
200-day SMA: | 68.23 | Buy |
8-day EMA: | 99.71 | Buy |
20-day EMA: | 95.49 | Buy |
50-day EMA: | 88.42 | Buy |
200-day EMA: | 70.99 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.58 | Buy |
20-day SMA: | 46.67 | Buy |
50-day SMA: | 46.11 | Buy |
200-day SMA: | 38.62 | Buy |
8-day EMA: | 45.67 | Buy |
20-day EMA: | 45.85 | Buy |
50-day EMA: | 45.2 | Buy |
200-day EMA: | 38.5 | Buy |
United States Lime & Minerals Earnings Growth & USLM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
United States Lime & Minerals Technical Analysis
Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |